San Francisco, California, March 23, 2021—Wave 80 Biosciences today announced a major expansion of its IP portfolio with the issuance of U.S. Patent 10,955,067, Methods and Systems for Enhanced [...]
Grant by United States Patent and Trademark Office covers groundbreaking Wave 80 technology for high-performance molecular assays, liquid biopsy, and other applications.
Strong NGO support cited for system's capacity for multiplexing and exceptionally high performance sample prep module
Dr. Daniel Laser, Wave 80’s Chief Executive Officer and President, will discuss major recent advances in the company’s bioassay technology as part of an invited talk at the upcoming Semicon [...]
